Purdue Pharma Files Plan to Settle Opioid Claims - Articles

All Content


Posted by: Stacey Shrader Joslin on Mar 20, 2025

Purdue Pharma's bankruptcy entered a new, possibly final phase this week when the bankrupt drugmaker filed a $7.4 billion plan to resolve thousands of lawsuits that alleged its OxyContin pain medication caused a widespread opioid addiction crisis. Reuters also reports on legal fees earned in the case. According to the news source, Purdue's lawyers at Davis Polk have received or requested more than a quarter of a billion dollars since the bankruptcy began in 2019.